Article

Adverse events induced by Burosumab treatment and prediction of drug target gene: a pharmacovigilance study based on the FDA adverse event reporting system (FAERS) database

2026-06-01

Abstract excerpt

<b>Aim:</b> Burosumab is a fully human monoclonal IgG1 antibody targeting fibroblast growth factor 23 (FGF23). This study utilized the FDA Adverse Event Reporting System (FAERS) database to systematically characterize adverse drug events (ADEs) associated with Burosumab and predict its drug target gene. <b>Methods:</b> FAERS data from Q1 2004 to Q4 2024 were extracted and cleaned. Disproportionality analysis using...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 43bb10d8-309b-5482-96f0-c397bc432a7e
DOI: 10.22541/authorea.15004099/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Adverse events induced by Burosumab treatment and prediction of drug target gene: a pharmacovigilance study based on the FDA adverse event reporting system (FAERS) databaseDOI 10.22541/authorea.15004099/v1Read

A real-world pharmacovigilance study of brentuximab vedotin based on the FAERS database from 2011 to 2024Semantic proximity Read

Analysis of the adverse effects of used clinical Antisense Oligonucleotide drugs in DMD patients based on the FAERS databaseSemantic proximity Read

Real-world safety profile of Enfortumab Vedotin: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS)Semantic proximity Read

Bridging pharmacovigilance and genetic insight: investigating drugs and indications for breast cancer risk in women with autoimmune diseases.Semantic proximity Read

Adverse event profile differences between Trastuzumab Emtansine and Trastuzumab Deruxtecan: a real-world, pharmacovigilance studySemantic proximity Read

Drug-induced glucose metabolism disorders: A disproportionality analysis based on the FAERS databaseSemantic proximity Read

A genomic-led strategy to anticipate drug safety effectsSemantic proximity Read

Signal Mining and Analysis of Adverse Events in Children Using Growth Hormones: A Real-World Study Based on FAERSSemantic proximity Read

Pharmacovigilance analysis of inclisiran:a real-world assessment based on the FAERS databaseSemantic proximity Read

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for TivozanibSemantic proximity Read

Analysis and Mining of Baloxavir Marboxil Adverse Event Signals in Elderly Patients Based on the FAERS DatabaseSemantic proximity Read